Posted on
MARS Bioimaging is seeking partners to better enable drug development and therapy monitoring for COVID-19 and other lung diseases
Background The current standard for definitive diagnosis of COVID-19 is the real-time reverse transcriptase-polymerase chain reaction (RT-PCR). While this is a highly sensitive and specific test for COVID-19, it does not measure the severity nor progress of the associated lung disease. Significance of CERN Technology/MARS imaging could help COVID-19 treatment monitoring and drug development Mars technology […]
- 0